---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-000643"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:27:43.359527+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Profound Medical announces PRO FAMILIA hospital completes 500th Sonalleve procedure

## Summary
- PRO FAMILIA Specialist Hospital in Rzeszów, Poland performed its 500th Sonalleve MRI-guided focused ultrasound procedure.
- Sonalleve provides non-surgical treatment for uterine fibroids and adenomyosis, with no incisions, no blood loss, and no overnight stay.
- Over 4,000 women treated globally with 10 Sonalleve devices in Europe, China, and Southeast Asia.
- CEO Arun Menawat notes Sonalleve international growth while U.S. focus remains on TULSA-PRO commercialization.
- Approximately $10 million in research grants from European and Canadian organizations over five years for Sonalleve studies.

## SEC filing metadata
- accession: 0001171843-26-000643
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326000643/0001171843-26-000643-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326000643/f8k_020526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-000643
- JSON: https://secwatch.observer/filing/0001171843-26-000643.json
- Plain text: https://secwatch.observer/filing/0001171843-26-000643.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.